Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Aurora BayCare Medical Center
1650
mi
from 98109
Green Bay, WI
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Aurora BayCare Medical Center
1650
mi
from 98109
Green Bay, WI
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Aurora Saint Lukes Medical Center
1687
mi
from 98109
Milwaukee, WI
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Aurora Saint Lukes Medical Center
1687
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Aurora West Allis Medical Center
1683
mi
from 98109
West Allis, WI
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Aurora West Allis Medical Center
1683
mi
from 98109
West Allis, WI
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
BCCA - Cancer Centre for the Southern Interior
202
mi
from 98109
Kelowna,
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
BCCA - Cancer Centre for the Southern Interior
202
mi
from 98109
Kelowna,
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente-Rancho Cordova Cancer Center
626
mi
from 98109
Rancho Cordova, CA
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente-Rancho Cordova Cancer Center
626
mi
from 98109
Rancho Cordova, CA
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Leeward Radiation Oncology Center
2683
mi
from 98109
'Ewa Beach, HI
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Leeward Radiation Oncology Center
2683
mi
from 98109
'Ewa Beach, HI
Click here to add this to my saved trials
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1220
mi
from 98109
Tucson, AZ
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1220
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1782
mi
from 98109
Little Rock, AR
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2449
mi
from 98109
Jacksonville, FL
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2449
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2708
mi
from 98109
Margate, FL
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2708
mi
from 98109
Margate, FL
Click here to add this to my saved trials
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2091
mi
from 98109
Metairie, LA
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2091
mi
from 98109
Metairie, LA
Click here to add this to my saved trials
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2403
mi
from 98109
Summerville, SC
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2403
mi
from 98109
Summerville, SC
Click here to add this to my saved trials
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1890
mi
from 98109
Houston, TX
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
711
mi
from 98109
Riverton, UT
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
711
mi
from 98109
Riverton, UT
Click here to add this to my saved trials
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2348
mi
from 98109
Richmond, VA
The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2348
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming With Decitabine in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS): A Phase 1/2 Study
Status: Enrolling
Updated:  12/31/1969
Kadlec Clinic Hematology and Oncology
179
mi
from 98109
Kennewick, WA
Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming With Decitabine in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS): A Phase 1/2 Study
Status: Enrolling
Updated: 12/31/1969
Kadlec Clinic Hematology and Oncology
179
mi
from 98109
Kennewick, WA
Click here to add this to my saved trials
Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming With Decitabine in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS): A Phase 1/2 Study
Status: Enrolling
Updated:  12/31/1969
EvergreenHealth Medical Center
7
mi
from 98109
Kirkland, WA
Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming With Decitabine in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS): A Phase 1/2 Study
Status: Enrolling
Updated: 12/31/1969
EvergreenHealth Medical Center
7
mi
from 98109
Kirkland, WA
Click here to add this to my saved trials
Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming With Decitabine in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS): A Phase 1/2 Study
Status: Enrolling
Updated:  12/31/1969
Fred Hutch/University of Washington Cancer Consortium
9
mi
from 98109
Seattle, WA
Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming With Decitabine in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS): A Phase 1/2 Study
Status: Enrolling
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
9
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
University of Alabama Birmingham Hospital- UAB
2080
mi
from 98109
Birmingham, AL
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
University of Alabama Birmingham Hospital- UAB
2080
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
University of Arizona, University Medical Center
1220
mi
from 98109
Tucson, AZ
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
University of Arizona, University Medical Center
1220
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Keck Hospital of the University of Southern California
963
mi
from 98109
Los Angeles, CA
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Keck Hospital of the University of Southern California
963
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Stanford University
705
mi
from 98109
Stanford, CA
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Stanford University
705
mi
from 98109
Stanford, CA
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
University of Miami Hospital - University of Miami School of Medicine
2729
mi
from 98109
Miami, FL
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
University of Miami Hospital - University of Miami School of Medicine
2729
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Emory University School of Medicine
2180
mi
from 98109
Atlanta, GA
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Emory University School of Medicine
2180
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Medical College of Georgia at Georgia Regents University
2300
mi
from 98109
Augusta, GA
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Medical College of Georgia at Georgia Regents University
2300
mi
from 98109
Augusta, GA
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Northwestern Memorial Hospital-Northwestern University Feinberg School of Medicine
1733
mi
from 98109
Chicago, IL
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Northwestern Memorial Hospital-Northwestern University Feinberg School of Medicine
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
John Hopkins Bayview Medical Center
2328
mi
from 98109
Baltimore, MD
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
John Hopkins Bayview Medical Center
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Brigham & Women's Hospital - Harvard
2485
mi
from 98109
Boston, MA
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Brigham & Women's Hospital - Harvard
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hospital
1930
mi
from 98109
Detroit, MI
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital
1930
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
North Shore Jewish Medical Center
2413
mi
from 98109
Manhasset, NY
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
North Shore Jewish Medical Center
2413
mi
from 98109
Manhasset, NY
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
New York University School of Medicine
2402
mi
from 98109
New York, NY
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center/NY Presbyterian Hospital
877
mi
from 98109
New York, NY
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center/NY Presbyterian Hospital
877
mi
from 98109
New York, NY
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati UC Health University Hospital
1966
mi
from 98109
Cincinnati, OH
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati UC Health University Hospital
1966
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Geisinger Medical Center
2273
mi
from 98109
Danville, PA
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Center
2273
mi
from 98109
Danville, PA
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
2134
mi
from 98109
Pittsburgh, PA
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
University of Washington Medical Center
2
mi
from 98109
Seattle, WA
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
University of Washington Medical Center
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Minnesota Epilepsy Group
1400
mi
from 98109
Saint Paul, MN
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Minnesota Epilepsy Group
1400
mi
from 98109
Saint Paul, MN
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Health - Wake Forest University School of Medicine
2274
mi
from 98109
Winston-Salem, NC
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Health - Wake Forest University School of Medicine
2274
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
Evaluation of CRB in PROM Patients
Randomized Study to Compare the Cook Cervical Ripening Balloon Plus Pitocin to Pitocin Alone in PROM Patients
Status: Enrolling
Updated:  12/31/1969
University of South Florida
2523
mi
from 98109
Tampa, FL
Evaluation of CRB in PROM Patients
Randomized Study to Compare the Cook Cervical Ripening Balloon Plus Pitocin to Pitocin Alone in PROM Patients
Status: Enrolling
Updated: 12/31/1969
University of South Florida
2523
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Evaluation of CRB in PROM Patients
Randomized Study to Compare the Cook Cervical Ripening Balloon Plus Pitocin to Pitocin Alone in PROM Patients
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
1884
mi
from 98109
Houston, TX
Evaluation of CRB in PROM Patients
Randomized Study to Compare the Cook Cervical Ripening Balloon Plus Pitocin to Pitocin Alone in PROM Patients
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
1884
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Evaluation of CRB in PROM Patients
Randomized Study to Compare the Cook Cervical Ripening Balloon Plus Pitocin to Pitocin Alone in PROM Patients
Status: Enrolling
Updated:  12/31/1969
Tucson Medical Center (TMC)
mi
from 98109
Tucson, AZ
Evaluation of CRB in PROM Patients
Randomized Study to Compare the Cook Cervical Ripening Balloon Plus Pitocin to Pitocin Alone in PROM Patients
Status: Enrolling
Updated: 12/31/1969
Tucson Medical Center (TMC)
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
Evaluation of CRB in PROM Patients
Randomized Study to Compare the Cook Cervical Ripening Balloon Plus Pitocin to Pitocin Alone in PROM Patients
Status: Enrolling
Updated:  12/31/1969
Kosair Children's Hospital Maternal Fetal Medicine Specialists
mi
from 98109
Louisville, KY
Evaluation of CRB in PROM Patients
Randomized Study to Compare the Cook Cervical Ripening Balloon Plus Pitocin to Pitocin Alone in PROM Patients
Status: Enrolling
Updated: 12/31/1969
Kosair Children's Hospital Maternal Fetal Medicine Specialists
mi
from 98109
Louisville, KY
Click here to add this to my saved trials
The Women's Health Study: From Adolescence to Adulthood
The Women's Health Study: From Adolescence to Adulthood Sponsored by the Boston Center for Endometriosis.
Status: Enrolling
Updated:  12/31/1969
Boston Children's Hospital
2485
mi
from 98109
Boston, MA
The Women's Health Study: From Adolescence to Adulthood
The Women's Health Study: From Adolescence to Adulthood Sponsored by the Boston Center for Endometriosis.
Status: Enrolling
Updated: 12/31/1969
Boston Children's Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
The Women's Health Study: From Adolescence to Adulthood
The Women's Health Study: From Adolescence to Adulthood Sponsored by the Boston Center for Endometriosis.
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
The Women's Health Study: From Adolescence to Adulthood
The Women's Health Study: From Adolescence to Adulthood Sponsored by the Boston Center for Endometriosis.
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL)
Adipose Tissue Angiogenesis in Polycystic Ovary Syndrome (PCOS)
Status: Enrolling
Updated:  12/31/1969
Translational Research Institute for Metabolism and Diabetes
2544
mi
from 98109
Orlando, FL
Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL)
Adipose Tissue Angiogenesis in Polycystic Ovary Syndrome (PCOS)
Status: Enrolling
Updated: 12/31/1969
Translational Research Institute for Metabolism and Diabetes
2544
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
Broccoli Sprout Extract in Treating Patients With Breast Cancer
A Pilot Study of Broccoli Sprout Extract in Patients With Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Roswell Park Cancer Institute
2110
mi
from 98109
Buffalo, NY
Broccoli Sprout Extract in Treating Patients With Breast Cancer
A Pilot Study of Broccoli Sprout Extract in Patients With Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Roswell Park Cancer Institute
2110
mi
from 98109
Buffalo, NY
Click here to add this to my saved trials
Hybrid PET/MR in the Therapy of Cervical Cancer
Hybrid PET/MR in the Therapy of Cervical Cancer: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Hybrid PET/MR in the Therapy of Cervical Cancer
Hybrid PET/MR in the Therapy of Cervical Cancer: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
Psychosexual Intervention for Gynecologic and Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
The Ohio State University Comprehensive Cancer Center
2006
mi
from 98109
Columbus, OH
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
Psychosexual Intervention for Gynecologic and Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
The Ohio State University Comprehensive Cancer Center
2006
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
An Open Label, Dose-Escalation Study to Evaluate Safety, Tolerability, Maximum Tolerated Dose (MTD), Efficacy, and Pharmacokinetics (PKs) of CPI-613 Given With High Dose Cytarabine and Mitoxantrone in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Comprehensive Cancer Center of Wake Forest University
2279
mi
from 98109
Winston-Salem, NC
CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
An Open Label, Dose-Escalation Study to Evaluate Safety, Tolerability, Maximum Tolerated Dose (MTD), Efficacy, and Pharmacokinetics (PKs) of CPI-613 Given With High Dose Cytarabine and Mitoxantrone in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Comprehensive Cancer Center of Wake Forest University
2279
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials